Impact of Ergocalciferol Treatment of Vitamin D Deficiency on Serum Parathyroid Hormone Concentrations in Chronic Kidney Disease
- 11 January 2007
- journal article
- clinical trial
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 27 (1), 36-43
- https://doi.org/10.1159/000098561
Abstract
Vitamin D deficiency is highly prevalent and associated with secondary hyperparathyroidism in patients with chronic kidney disease (CKD). The Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines recommend treatment of vitamin D deficiency starting with CKD stage 3, though no data are available showing an impact on serum parathyroid hormone (PTH) concentrations. The goal of this analysis, therefore, was to determine the effect of ergocalciferol treatment on plasma PTH concentrations in vitamin D-deficient patients with stage 3 and stage 4 CKD. A prospective, nonrandomized observational analysis was conducted in an academic community hospital CKD clinic. Fifty-two patients with stage 3 or stage 4 CKD with vitamin D deficiency and elevated PTH concentrations received ergocalciferol dosed per a modified K/DOQI guidelines protocol and adjusted every 3 months. Serum PTH, 25-vitamin D, 1,25-vitamin D, calcium, phosphorus, and albumin levels were drawn at initiation of therapy and repeated every 3 months. The mean 25-vitamin D levels normalized in patients with stage 3 and 4 CKD, with values of 31.6 +/- 2.2 ng/ml (78.8 +/- 5.49 nmol/l) and 35.4 +/- 1.9 ng/ml (88.4 +/- 4.74 nmol/l), respectively (p < 0.0001). A median decrease in PTH concentrations of 13.1 and 2.0% was noted in patients with stage 3 and stage 4 CKD, respectively (p = 0.041, p = nonsignificant). Ergocalciferol therapy is a reasonable initial therapy for vitamin D deficiency associated with elevated PTH levels in stage 3 CKD. It does not appear to have equivalent benefits in stage 4 CKD.Keywords
This publication has 38 references indexed in Scilit:
- Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKDAmerican Journal of Kidney Diseases, 2006
- Autocrine Metabolism of Vitamin D in Normal and Malignant Breast TissueClinical Cancer Research, 2005
- Human Vascular Smooth Muscle Cells Undergo Vesicle-Mediated Calcification in Response to Changes in Extracellular Calcium and Phosphate ConcentrationsJournal of the American Society of Nephrology, 2004
- Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health StudyArthritis & Rheumatism, 2004
- Pathogenesis of secondary hyperparathyroidismKidney International, 1999
- Homeostasis of Phosphate RevisitedNephron, 1997
- Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of HyperparathyroidismNephrology Dialysis Transplantation, 1991
- AGE, VITAMIN D, AND SOLAR ULTRAVIOLETThe Lancet, 1989
- Vitamin-D Synthesis and Metabolism after Ultraviolet Irradiation of Normal and Vitamin-D-Deficient SubjectsNew England Journal of Medicine, 1982
- NORMAL PLASMA-1,25-(OH)2-VITAMIN-D CONCENTRATIONS IN NUTRITIONAL OSTEOMALACIAThe Lancet, 1979